Patients with refractory and difficult-to-treat Inflammatory Bowel Disease are underrepresented in randomized clinical trials

被引：0
|
作者：
Parigi, T. L. [1 ,2 ,3 ]
Solitano, V [4 ,5 ]
Mekonnen, H. [5 ]
Yuan, Y. [5 ]
Jairath, V [5 ]
Danese, S. [3 ]
机构：
[1] IRCCS San Raffaele Hosp, Dept Gastroenterol & Endoscopy, Milan, Italy
[2] Case Western Reserve Univ, Dept Pathol, Cleveland, OH USA
[3] Univ Vita Salute San Raffaele, Div Immunol Transplantat & Infect Dis, Milan, Italy
[4] Univ Vita Salute San Raffaele, Div Immunol Transplantat & Infect Dis, Milan, Italy
[5] Western Univ, Dept Med, Div Gastroenterol, London, ON, Canada
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.1332
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1158
引用
收藏
页码：I2114 / I2115
页数：2
相关论文
共 50 条
  • [41] The concept of difficult-to-treat disease in rheumatology: where next?
    Nagy, Gyorgy
    Gunkl-Toth, Lilla
    Dorgo, Andras M.
    Mcinnes, Iain B.
    LANCET RHEUMATOLOGY, 2025, 7 (04): : e274 - e289
  • [42] Infections with C. difficile in inflammatory bowel disease patients are difficult to treat and frequently recur
    Gombotz, E.
    Leitner, E.
    Zollner-Schwetz, I.
    Krause, R.
    Kornschober, C.
    Wenzl, H.
    Kump, P.
    Petritsch, W.
    Hogenauer, C.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S484 - S485
  • [43] Pharmacotherapeutic and Non-Pharmacological Options for Refractory and Difficult-to-Treat Seizures
    Mitchell, James W.
    Seri, Stefano
    Cavanna, Andrea E.
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2012, 4 : 105 - 115
  • [44] ASSESSING OUTCOME IN RANDOMIZED CLINICAL-TRIALS - INFLAMMATORY BOWEL-DISEASE
    IRVINE, EJ
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 1993, 7 (07): : 561 - 567
  • [45] The fragility of randomized clinical trials in evaluating novel therapies for Inflammatory Bowel Disease
    Chen, R.
    Zheng, J.
    Huang, P.
    Li, L.
    Chen, M.
    Zhang, S.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1414 - i1414
  • [46] Clinical Characteristics of Difficult-to-Treat Gout Patients: a Principal Components Analysis.
    Vaysbrot, Elizaveta
    Lee, Yoojin
    McLaughlin, Sarah
    Agashivala, Neetu
    Yadao, Anthony
    McAlindon, Timothy E.
    Harvey, William F.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S403 - S404
  • [47] Patient and disease characteristics suggest difficult-to-treat PsA
    Di Lellis, Maddalena Angela
    AKTUELLE RHEUMATOLOGIE, 2025, 50 (02) : 112 - 112
  • [48] Antihistamine updosing reduces disease activity in patients with difficult-to-treat cholinergic urticaria
    Koch, Katja
    Weller, Karsten
    Werner, Andreas
    Maurer, Marcus
    Altrichter, Sabine
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 138 (05) : 1483 - +
  • [49] The Future of Clinical Trials in Inflammatory Bowel Disease
    Ma, Christopher
    Solitano, Virginia
    Danese, Silvio
    Jairath, Vipul
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2025, 23 (03) : 480 - 489
  • [50] A Closer Look at the Difficult-to-Treat Rheumatoid Arthritis Patients
    Gazel, Ummugulsum
    Acikgoz, Seyyid
    Chowdhury, Rokhsana
    Ivory, Catherine
    Zahrai, Amin
    Hepworth, Elliot
    Aydin, Sibel
    JOURNAL OF RHEUMATOLOGY, 2023, 50 (07) : 43 - 44
12345